Pack of 10 Units
Old MRP ₹110.4
MRP ₹103.5
₹82.8
₹10.35/Units
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
CompositionOlmepath 20 MG Tablet 10 is used to control high blood pressure (hypertension). Containing olmesartan, it relaxes blood vessels, improving circulation. This action lowers blood pressure and reduces the risk of heart attack, stroke, and kidney problems. It is particularly useful in combination with other antihypertensive agents for effective hypertension management.
Olmepath 20 MG Tablet 10 is used solely for the management of high blood pressure (hypertension). It works by blocking the action of Angiotensin II, causing blood vessels to relax and widen. It helps reduce the overall risk of associated cardiovascular events.
Swallow the tablet whole with a glass of water.
Do not chew or crush the tablet.
It can be taken with or without food.
Remember not to stop taking this medicine without consulting your doctor.
Olmepath 20 MG Tablet 10 is taken orally.
Olmepath 20 MG Tablet 10 may cause side effects like dizziness, diarrhoea, nausea, tiredness, flu-like symptoms and muscle or joint pain. If these side effects persist or bother you, consult your doctor.
Most side effects are temporary and generally harmless, which resolve on discontinuing the use of Olmepath 20 MG Tablet 10. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor.
Here are some general guidelines for managing common side effects:
Diarrhoea: Consider taking Olmepath 20 MG Tablet 10 with food, as it might lessen this effect.
Nausea: Try taking this medicine after meals to reduce feelings of sickness.
Olmepath 20 MG Tablet 10 contains olmesartan medoxomil (20 mg), which has the following effects on the body:
Angiotensin II Receptor Blockade: Olmesartan selectively blocks the binding of angiotensin II to its receptor, specifically the AT1 subtype. Angiotensin II is a hormone that causes blood vessels to narrow or constrict, increasing blood pressure.
Blood Vessel Relaxation: By blocking angiotensin II's action on its receptor, Olmesartan causes blood vessels to relax and widen. This decreases the resistance the heart needs to pump against, ultimately reducing blood pressure.
Long-Lasting Effect: Olmesartan's blood pressure-lowering effect lasts over 24 hours. This long-lasting effect helps manage hypertension effectively throughout the day.
Olmepath 20 MG Tablet 10 is contraindicated during the second and third trimesters of pregnancy. If you are pregnant or planning to conceive, consult this with your doctor before starting this medicine.
Olmepath 20 MG Tablet 10 is not recommended for breastfeeding women. Consult your doctor to understand the potential risks and benefits.
Caution is advised while consuming alcohol when taking Olmepath 20 MG Tablet 10, as it may enhance some side effects. Consult your doctor about safe levels of alcohol consumption.
If you have liver problems, consult with your doctor before starting Olmepath 20 MG Tablet 10. This medicine may affect liver function.
Caution is advised before using Olmepath 20 MG Tablet 10 if you have a history of any kidney problems. Consult your doctor before taking this medicine.
Olmepath 20 MG Tablet 10 might cause dizziness or tiredness. If you experience these symptoms, avoid driving or operating heavy machinery. Consulting your doctor beforehand is a wise step.
If you are allergic to olmesartan medoxomil or any other ingredients in Olmepath 20 MG Tablet 10, do not take this medicine. Please consult with your doctor for the best advice.
Caution is advised while giving Olmepath 20 MG Tablet 10 to children under 18 years of age. Always consult your doctor before giving any medicine to a child.
Older patients should take Olmepath 20 MG Tablet 10 under medical supervision as they may be more susceptible to its side effects. Your doctor will guide you based on your health status.
Olmepath 20 MG Tablet 10 interacts with the following medicines:
Diuretics: Medicines like furosemide or hydrochlorothiazide may interact with Olmepath 20 MG Tablet 10, increasing the risk of low blood pressure and kidney dysfunction.
Potassium Supplements: Supplements like potassium chloride, when taken alongside Olmepath 20 MG Tablet 10, could potentially lead to high potassium levels in your blood (hyperkalaemia).
Antimanic Medications: Medications containing lithium should not be taken concurrently with this tablet, as it can lead to an increased risk of lithium toxicity.
None
Olmepath 20 MG Tablet 10 interacts with the following diseases:
Kidney Disease: If you have a kidney disease, you should only take this medicine under close medical supervision as it can worsen renal function.
Liver Problems: Patients with liver problems may have increased medicine levels; therefore, a reduced dose may be necessary.
Dehydration: The risk of low blood pressure could be higher in dehydrated patients or those taking high-dose diuretics.
Coronary Artery Disease: In rare cases, this medicine might worsen angina or cause heart attacks.
The daily dose of Olmepath 20 MG Tablet 10 should be taken as directed by your doctor. The dosage may vary based on individual factors, such as how severe your condition is and how you respond to the medication. Always follow your doctor's prescribed dosage and do not exceed it without consulting your doctor.
In the event of an overdose of Olmepath 20 MG Tablet 10, common symptoms can include dizziness, headache, and increased heartbeat. If these symptoms persist or worsen, it's important to inform your doctor.
If you've forgotten to take your Olmepath 20 MG Tablet 10, take it as soon as you remember. However, if it's nearly time for the next dose, skip the one you missed and continue with your regular schedule. Don't increase your dosage without consulting your doctor.
Store Olmepath 20 MG Tablet 10 at room temperature, between 20°C to 25°C.
Keep the medicine away from light and dampness, retaining it in its original packaging.
Ensure the medicine is kept out of reach of children.
Always check the expiry date and only use the product before this date.
Reduce your salt intake: High salt consumption can raise your blood pressure, worsening hypertension.
Regular exercise: Regularly engage in physical activities like walking, cycling or swimming.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Hypertension, Kidney Problems, Heart Complications |
| Drug Category | Angiotensin II Receptor Antagonist |
| Therapeutic Category | Antihypertensives |
No, Olmepath 20 MG Tablet 10 can cause harm or even death to the unborn child during the 2nd and 3rd trimesters of pregnancy. It's also not recommended for nursing mothers.
Typically, you might notice a reduction in your high blood pressure within a week of starting the medicine, with the maximum effect visible in 2-4 weeks.
If you miss a dose, take it as soon as you remember. However, if it's nearly time for the next dose, skip the missed one. Avoid doubling up doses.
Yes, but only if your doctor recommends it. It's important to avoid combining this medicine with aliskiren if you're diabetic or with ACE inhibitors or other ARBs.
Absolutely! Regular exercise, a balanced diet low in salt and fat, stress management, maintaining a healthy weight, limiting alcohol intake and quitting smoking can all help maximise benefits.
Abruptly stopping any blood pressure medicine like Olmepath 20 MG Tablet 10 can potentially cause your blood pressure to spike. Always consult your doctor before making changes.
If you believe you've taken too much of this medicine and experience symptoms such as dizziness or a fast heartbeat, seek immediate medical attention.
Check out Editorial Policy
U.S. National Library of Medicine. (n.d.). Dailymed - OLMESARTAN MEDOXOMIL- olmesartan medoxomil tablet, film coated. Retrieved April 1, 2024, from https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c42da0af-84dd-4220-bd40-139be51e8c00
U.S. Food and Drug Administration. (2002). Olmesartan medoxomil. Retrieved April 1, 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21286lbl.pdf
Al-Majed, A. A., Bakheit, A. H. H., Abdel Aziz, H. A., & Al-Jallal, A. A. M. (2017). Olmesartan. Profiles of drug substances, excipients, and related methodology, 42, 241–286. https://doi.org/10.1016/bs.podrm.2017.02.005
Wang, J., Sun, N., Ke, Y., Zhang, B., Ikegami, N., & Zhu, J. (2012). Long-Term efficacy of olmesartan medoxomil in Chinese hypertensive patients as assessed by clinic, ambulatory and home blood pressure measurements. Clinical Drug Investigation, 32(11), 729–734. https://doi.org/10.1007/s40261-012-0003-7
González, R., Peña, M. Á., & Torrado, G. (2022). Formulation and evaluation of Olmesartan Medoxomil tablets. Compounds, 2(4), 334–352. https://doi.org/10.3390/compounds2040028
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
50.1% CHEAPER
7154 users bought this instead
Read More
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaAll MedicinesAll BrandsNeed HelpFAQSecuritySubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.8.2
2025 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
